Willow Biosciences Inc. (TSE:WLLW – Get Free Report) shares hit a new 52-week low during trading on Monday . The stock traded as low as C$0.07 and last traded at C$0.07, with a volume of 103121 shares traded. The stock had previously closed at C$0.08.
Willow Biosciences Stock Performance
The firm has a market cap of C$8.65 million, a price-to-earnings ratio of -1.00 and a beta of 1.13. The firm’s 50 day moving average price is C$0.09 and its 200-day moving average price is C$0.10. The company has a debt-to-equity ratio of 131.61, a current ratio of 0.70 and a quick ratio of 19.71.
Willow Biosciences Company Profile
Willow Biosciences Inc, a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation.
See Also
- Five stocks we like better than Willow Biosciences
- Best Stocks Under $5.00
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- What Are Trending Stocks? Trending Stocks Explained
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
